Nutriband Inc Total Liabilities
Nutriband Inc total liabilities. Based on the latest financial reports, Nutriband Inc (NTRB) has total liabilities worth $964.36K USD as of July 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NTRB asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Nutriband Inc (2016–2026)
Total liabilities of Nutriband Inc from 2016 to 2026. This chart illustrates how Nutriband Inc's total liabilities have evolved over time, based on quarterly financial data.
Nutriband Inc Competitors by Total Liabilities
The table below lists competitors of Nutriband Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Airship AI Holdings Inc
NASDAQ:AISP
|
USA | $26.37 Billion |
|
Se Gyung Hi Tech Co.Ltd
KQ:148150
|
Korea | ₩111.76 Billion |
|
Pioneer Credit Ltd
AU:PNC
|
Australia | AU$325.86 Million |
|
EverFocus Electronics Corp
TW:5484
|
Taiwan | NT$344.51 Million |
|
Real Estate & E-Commerce Split Corp
TO:RS
|
Canada | CA$117.81 Million |
|
Anterogen.Co.Ltd
KQ:065660
|
Korea | ₩1.40 Billion |
|
AGFA Gevaert NV
BR:AGFB
|
Belgium | €1.00 Billion |
|
Aniplus Inc
KQ:310200
|
Korea | ₩143.19 Billion |
Liability Composition Analysis (2016–2026)
This chart breaks down Nutriband Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nutriband Inc asset portfolio.
Liquidity & Leverage Metrics
Nutriband Inc Total Liabilities Ratios Explained
Nutriband Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nutriband Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nutriband Inc (2016–2026)
The table below shows the annual total liabilities of Nutriband Inc from 2016 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-01-31 | $868.45K | -16.58% |
| 2025-01-31 | $1.04 Million | -3.51% |
| 2024-01-31 | $1.08 Million | +22.13% |
| 2023-01-31 | $883.39K | +0.34% |
| 2022-01-31 | $880.38K | -68.73% |
| 2021-01-31 | $2.82 Million | +39.22% |
| 2020-01-31 | $2.02 Million | +401.81% |
| 2019-01-31 | $403.01K | +828.78% |
| 2018-01-31 | $43.39K | +196.83% |
| 2017-01-31 | $14.62K | +23.88% |
| 2016-01-31 | $11.80K | -- |
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company… Read more